April 24, 2018 : DCMS #394

DISASTERS AVERTED — Near Miss Case Studies

When Pills Are Hard to Swallow, Find Alternatives

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

George Bakris Part 1, Introduction and Diabetic Kidney Disease

HOMERUN SLIDES — Great Clinical Presentation Highlights

Hypertension Update 2018 Part 7

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #122: The Insulin Resistance Syndrome Part 3

MOST POPULAR ARTICLES OF THE MONTH

#1 How Many Types of Diabetes Are There? Two? Five? Or Eleven?
#2 New Way to Screen for Diabetes and Prediabetes
#3 A Summary of ADA’s New 2018 Standards of Medical Care in Diabetes

Last week we had some great Homerun Slides on Albuminuria. We generated a lot of interest in what is the best way to ward off Kidney Disease. So this week we have an exclusive interview with one of the most well known names in Kidney Disease, Dr. George Bakris. During the next few weeks, Dr Bakris, who has published over 150 papers and participated in the landmark ACCORD study, will be sharing one on one with our publisher his ideas on treating hypertension, diabetes, and preventing kidney disease.

Dave Joffe

Editor-in-chief

Woman, 67 years of age, newly diagnosed with type 2 diabetes with an A1C of 7.8%. Met with PCP who prescribed metformin ER and referred patient for diabetes education. Patient made some dietary and physical activity changes at first, but upon return visit her A1C was 8.5%. She reported she did not take the metformin. “I can’t swallow big pills. The bottle said not to crush or break the tablets. They were just too big to swallow. So then I just gave up on everything.”

Dr. George Bakris talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about what he is looking forward to in the results of some promising diabetes trials.

In this week’s Homerun Slides, understanding blood pressure classification.

Adipose-derived markers and insulin resistance: Whilst rising BMI or waist circumference are clearly linked to insulin resistance and risk for T2DM, a number of adipose-derived factors have attracted interest with respect to determining insulin resistance. Adiponectin, as recently reviewed, has been the most notable of these biomarkers. Adiponectin is unlike the other adipocyte hormones in that its concentrations decline with rising obesity. Therefore low levels predict higher risk for T2DM but there are a number of complexities in this relationship.

More specific classifications for the disease could lead to more personalized treatments in the future. Is it time?

Dental exams may be earlier predictor of disease than even blood tests.

Comprehensive recommendations feature notable new recommendations for people with cardiovascular disease and diabetes.